Dr. Linda DiMeglio, MD
Claim this profileIndiana University - Riley Hospital for Children
Studies Type 1 Diabetes
Studies Diabetes
10 reported clinical trials
18 drugs studied
Area of expertise
1Type 1 Diabetes
mIAA positive
IA-2A positive
ZnT8A positive
2Diabetes
IAA positive
IA-2 positive
ZnT8 positive
Affiliated Hospitals
Clinical Trials Linda DiMeglio, MD is currently running
Rituximab + Abatacept
for Type 1 Diabetes
This trial is testing whether a combination of two drugs, rituximab-pvvr followed by abatacept, can better preserve insulin production in people newly diagnosed with Type 1 Diabetes compared to rituximab-pvvr alone. Rituximab-pvvr works by reducing harmful immune cells, while abatacept helps calm the immune system. The goal is to see if this combination can improve insulin production and overall diabetes management.
Recruiting0 awards Phase 220 criteria
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
More about Linda DiMeglio, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Linda DiMeglio, MD has experience with
- Placebo
- Glucagon Nasal Powder [Baqsimi]
- Insulin Aspart
- Insulin Lispro
- Insulin Glulisine
- Basal Insulin
Breakdown of trials Linda DiMeglio, MD has run
Type 1 Diabetes
Diabetes
Type 2 Diabetes
Low Blood Sugar
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Linda DiMeglio, MD specialize in?
Linda DiMeglio, MD focuses on Type 1 Diabetes and Diabetes. In particular, much of their work with Type 1 Diabetes has involved mIAA positive patients, or patients who are IA-2A positive.
Is Linda DiMeglio, MD currently recruiting for clinical trials?
Yes, Linda DiMeglio, MD is currently recruiting for 5 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Linda DiMeglio, MD has studied deeply?
Yes, Linda DiMeglio, MD has studied treatments such as Placebo, Glucagon Nasal Powder [Baqsimi], Insulin Aspart.
What is the best way to schedule an appointment with Linda DiMeglio, MD?
Apply for one of the trials that Linda DiMeglio, MD is conducting.
What is the office address of Linda DiMeglio, MD?
The office of Linda DiMeglio, MD is located at: Indiana University - Riley Hospital for Children, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University - Riley Hospital for Children.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.